par Martel, Samuel;Maurer, Christian;Lambertini, Matteo
;Pondé, Noam;de Azambuja, Evandro 
Référence Expert opinion on drug safety, 16, 9, page (1021-1038)
Publication Publié, 2017-09


Référence Expert opinion on drug safety, 16, 9, page (1021-1038)
Publication Publié, 2017-09
Article révisé par les pairs
Titre: |
|
Auteur: | Martel, Samuel; Maurer, Christian; Lambertini, Matteo; Pondé, Noam; de Azambuja, Evandro |
Informations sur la publication: | Expert opinion on drug safety, 16, 9, page (1021-1038) |
Statut de publication: | Publié, 2017-09 |
Sujet CREF: | Pharmacologie |
Mots-clés: | Anti-HER2 agents |
breast cancer | |
cardiac biomarkers | |
cardiac imaging | |
cardiac risk assessment | |
cardiotoxicity | |
CDK4/6 inhibitors | |
chemotherapy | |
endocrine therapy | |
Note générale: | SCOPUS: re.j |
Langue: | Anglais |
Identificateurs: | urn:issn:1474-0338 |
info:doi/10.1080/14740338.2017.1351541 | |
info:scp/85028670769 | |
info:pmid/28697311 |